Galderma Total Assets from 2010 to 2026
| GALD Stock | 154.20 0.40 0.26% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 14.5 B | Current Value 12.7 B | Quarterly Volatility 862 M |
Check Galderma Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Galderma Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.5 M, Interest Expense of 418 M or Selling General Administrative of 495.8 M, as well as many indicators such as Price To Sales Ratio of 3.27, Dividend Yield of 0.0 or PTB Ratio of 3.29. Galderma financial statements analysis is a perfect complement when working with Galderma Group Valuation or Volatility modules.
Galderma | Total Assets |
The evolution of Total Assets for Galderma Group N provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Galderma Group compares to historical norms and industry peers.
Latest Galderma Group's Total Assets Growth Pattern
Below is the plot of the Total Assets of Galderma Group N over the last few years. Total assets refers to the total amount of Galderma Group assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Galderma Group N books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Galderma Group's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Galderma Group's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 12.62 B | 10 Years Trend |
|
Total Assets |
| Timeline |
Galderma Total Assets Regression Statistics
| Arithmetic Mean | 11,719,103,212 | |
| Geometric Mean | 11,691,826,014 | |
| Coefficient Of Variation | 7.36 | |
| Mean Deviation | 544,973,923 | |
| Median | 11,454,977,800 | |
| Standard Deviation | 861,951,759 | |
| Sample Variance | 742960.8T | |
| Range | 4B | |
| R-Value | 0.48 | |
| Mean Square Error | 611137.1T | |
| R-Squared | 0.23 | |
| Significance | 0.05 | |
| Slope | 81,654,405 | |
| Total Sum of Squares | 11887373.3T |
Galderma Total Assets History
About Galderma Group Financial Statements
Galderma Group investors use historical fundamental indicators, such as Galderma Group's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Galderma Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 14.5 B | 12.7 B | |
| Intangibles To Total Assets | 0.91 | 0.89 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Galderma Stock Analysis
When running Galderma Group's price analysis, check to measure Galderma Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galderma Group is operating at the current time. Most of Galderma Group's value examination focuses on studying past and present price action to predict the probability of Galderma Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galderma Group's price. Additionally, you may evaluate how the addition of Galderma Group to your portfolios can decrease your overall portfolio volatility.